Skip to Content
Søk Menu
2024

EADV | European Academy of Dermatology and Venereology

EADV 2024

Lone Skov

EADV 2024 – Still Unanswered Questions about Psoriasis and Psoriasis Treatment

/ Lone Skov
EADV24PsoriasisPsoriasisartrit Play the Video

Gå ikke glipp av det nyeste

Registrer deg og få nye artikler, MEDtalks og tidsskrifter direkte til din innboks.

Få adgang
Annarita Antelmi

A Large Proportion of Patients with Prurigo Nodularis Receive Several Different Treatment Combinations and Switches and a High Number of Healthcare Visits

/ Annarita Antelmi
EADV24 Play the Video

Deucravacitinib, A New Oral Option for Patients with Moderate to Severe Psoriasis

/ Sofie Pohl
Psoriasis

Topp 4 mest viste MEDtalks fra EADV 2024

Diagnostic Challenges for Immunobullous Disorders in Elderly Patients in Lagos

/ Dermatologi / Viola Ikebudu Adaeze

A lot of Factors Increase the Comorbidity at Atopic Dermatitis

/ Dermatologi / Giovanni Damiani

EADV 2024: Promising News in Hand Eczema Treatment

/ Dermatologi / Claus Otto Carl Zachariae

Safety Is One of the Main Drivers for Atopic Dermatitis Patient Preferences of Treatment

/ Dermatologi / Sascha D. W. Stave

EADV 2024

Andrew Blauvelt

LBA: Probably the Best in Class for Treatment of Plaque Psoriasis

/ Andrew Blauvelt
EADV24Psoriasis Play the Video
Thrasyvoulos Tzellos

AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data

/ Thrasyvoulos Tzellos
Atopisk dermatittEADV24 Play the Video
Christopher Willy Schwarz

Non-Medical Switches of Biosimilar in Psoriasis Treatment Appears Safe

/ Christopher Willy Schwarz
EADV24Psoriasis Play the Video
Katrine Elisabeth Karmisholt

High-Intensity Focused Ultrasound Reduced/Eliminated Tumors in 76% of Patients with Cutaneous Neurofibromas

/ Katrine Elisabeth Karmisholt
EADV24 Play the Video

LBA: Lebrikizumab Provides Long-Term Efficacy and Safety in Atopic Dermatitis with a Well-Tolerated Safety Profile

/ Jan Andreasen
Atopisk dermatittEADV24
Teo Helkkula

No Significant Changes in Incidence or Survival Rates of Acral Melanoma in Sweden

/ Teo Helkkula
EADV24 Play the Video
Load more

EADV 2023

Severe Alopecia Areata: JAK-Inhibitor Increases Hair Regrowth and Improve Quality of Life

/ Dermatologi / Bianca Maria Piraccini

Personalized Medicine on the Horizon for Atopic Dermatitis

/ Dermatologi / Marjolein de Bruin-Weller

Risk Factors for JAK-Inhibitor Treatment in Atopic Dermatitis

/ Dermatologi / Ida Vittrup

New Treatments for Atopic Dermatitis to Come

/ Dermatologi / Stephan Weidinger

Concentration of Ixekizumab Paving the Way Towards Personalized Therapy in Psoriasis

/ Dermatologi / Lisa Schots

New Insights into Type 2 Inflammation in Atopic Dermatitis

/ Dermatologi / Stephan Weidinger
Se oversigt

Deucravacitinib: Significantly Improved Symptoms and Signs of Psoriasis in Patients with Psoriasis

/ Dermatologi / Kim Papp

New Oral Drug Sotyktu for Plaque Psoriasis Patients Demonstrates Promising Results with Favorable Safety Profile

/ Dermatologi / Enikö Sonkoly

AD: New Knowledge About Type 2 Inflammation and Skin Barrier Deficiency

/ Dermatologi / Stephan Weidinger

An Overview of the Exciting News From EADV 2023

/ Dermatologi / Enikö Sonkoly

New and Promising Treatments for Psoriasis

/ Dermatologi / Andreas Pinter

IL-17 Targeted Drugs Signal Hope for Hidradenitis Suppurativa Patients

/ Dermatologi / Thrasyvoulos Tzellos

Latest Advancements in the Management of Psoriasis: Insights From EADV 2023

/ Dermatologi / Kristian Reich

Deucravacitinib in Psoriasis: Three-Year Safety and Efficacy Results

/ Dermatologi / April Armstrong

Promising Result for Patients with Prurigo Nodularis: Targeting IL-4 and IL-13 Signaling

/ Dermatologi / Martin Metz

Alopecia Areata: Are New Treatments a Real Breakthrough? 

/ Dermatologi / BestPractice Nordic

Early Detection and Prevention of Psoriatic Arthritis

/ Dermatologi / Wolf-Henning Boehncke

The Impact of Acne’s Anatomical Variations on Social Perception 

/ Dermatologi / BestPractice Nordic

EADV 2022

Therapies for atopic dermatitis for special populations of patients

/ Dermatologi / April Armstrong

Severe atopic dermatitis in a pediatric population – Epidemiology, pathophysiology, and comorbidities

/ Onkologi / Ida Vittrup

Treatment of severe atopic dermatitis in a pediatric population

/ Dermatologi / Ida Vittrup

Bacterial resistance in Hidradenitis suppurativa: an update

/ Dermatologi / Thrasyvoulos Tzellos

When are hormonal agents indicated in acne?

/ Dermatologi / Trinidad Montero-Vilchez

A Nationwide E-health Platform for Atopic Dermatitis

/ Dermatologi / Laura von Kobyletzki

New study sheds light on the link between atopic dermatitis and academic achievement in childhood and youth

/ Dermatologi / Ida Vittrup

The Relevance of AI in Dermatology

/ Dermatologi / Hans Peter Soyer

Gender Equity in Dermatology

/ Dermatologi / Deirdre Murrell

Treatment of Severe Atopic Dermatitis (AD)

/ Dermatologi / Pedro Mendes Bastos

The role of JAK and BTK inhibitors in dermatology

/ Dermatologi / Deirdre Murrell

Does smoking really cause psoriasis?

/ Dermatologi / Charlotte Näslund Koch

Personalised Dosing – Patient-centered Dupilumab Dosing Regimen in AD

/ Dermatologi / Lotte Spekhorst

Short-term topical therapies and anti-IL-23 treatment updates for patients with nail psoriasis

/ Dermatologi / BestPractice Nordic

JAK inhibitors for patients with alopecia areata 

/ Dermatologi / BestPractice Nordic

A New Approach in Treating Patients with Alopecia Areata

/ Dermatologi / Bianca Maria Piraccini

Nail psoriasis: best management and new insights

/ Dermatologi / Bertrand Richert

Adalimumab Biosimilars in Psoriasis

/ Dermatologi / Nikolai Loft

EADV 2021

How to recognize and manage hair dye allergy

/ Dermatologi / Annarita Antelmi

Existing and upcoming small molecules in psoriasis treatment

/ Dermatologi / Enikö Sonkoly

Sjögren’s syndrome is a common disease, but unfortunately neglected

/ Dermatologi / Filippa Nyberg
Se oversigt

Vaccine hesitancy driven by safety concerns

/ Dermatologi / Álvaro González-Cantero

The risk of infections in psoriasis patients treated with biologics during the COVID-19 pandemic

/ Dermatologi / Lara van der Schoot / Juul van den Reek

Psoriasis has significant negative impact on quality of life

/ Dermatologi / Dimitrios Ioannides
Back to top